Understanding Stroke: When Was tPA FDA Approved for Stroke?
•
4 min read
In 1996, the U.S. Food and Drug Administration (FDA) approved tissue plasminogen activator (tPA), also known as alteplase, for treating acute ischemic stroke. This decision was groundbreaking, providing the first pharmacological treatment to dissolve blood clots causing stroke and significantly influencing emergency stroke response protocols. This answered the critical question, 'When was tPA FDA approved for stroke?'.
